# Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer

> **NCT05512663** · NA · UNKNOWN · sponsor: **Jewish General Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Irreversible Electroporation (IRE)

## Key facts

- **NCT ID:** NCT05512663
- **Lead sponsor:** Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09
- **Primary completion:** 2024-09
- **Final completion:** 2024-09
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05512663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05512663, "Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05512663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*